SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-18-000021
Filing Date
2018-03-21
Accepted
2018-03-21 16:56:48
Documents
1
Period of Report
2018-03-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8-k2018x03x21.htm 8-K 58593
  Complete submission text file 0001610618-18-000021.txt   59768
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 18704994
SIC: 2836 Biological Products, (No Diagnostic Substances)